Precipio (NASDAQ:PRPO) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell?

Precipio, Inc. (NASDAQ:PRPO)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.30 and traded as high as $10.74. Precipio shares last traded at $10.14, with a volume of 77,637 shares trading hands.

Precipio Stock Performance

The company has a debt-to-equity ratio of 0.02, a current ratio of 0.73 and a quick ratio of 0.60. The stock has a market capitalization of $15.01 million, a PE ratio of -5.54 and a beta of 1.42. The stock has a 50 day moving average of $6.42 and a two-hundred day moving average of $6.30.

Institutional Trading of Precipio

An institutional investor recently bought a new position in Precipio stock. Renaissance Technologies LLC bought a new position in shares of Precipio, Inc. (NASDAQ:PRPO) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,100 shares of the biotechnology company’s stock, valued at approximately $56,000. Renaissance Technologies LLC owned approximately 0.68% of Precipio as of its most recent filing with the Securities and Exchange Commission (SEC). 10.45% of the stock is owned by hedge funds and other institutional investors.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.